This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Clostridioides difficile is a major cause of hospital-acquired diarrhea and a driver of nosocomial outbreaks, yet rapid, accurate ribotype identification remains challenging. We sought to develop a MALDI-TOF MS-based workflow coupled with machine learning to distinguish epidemic toxigenic ribotypes (RT027 and RT181) from other strains in real time. RESULTS: We analyzed MALDI-TOF spectra from 379 clinical isolates collected across ten Spanish hospitals and identified seven discriminant biomarker peaks. Two peaks (2463 and 4993 m/z) were uniquely associated with RT027, while combinations of five additional peaks reliably identified RT181. Our classifiers-implemented both in the commercial Clover MSDAS platform and the open-access AutoCdiff web tool-achieved up to 100% balanced accuracy in ribotype assignment and proved robust in real-time outbreak simulations. CONCLUSIONS: This study demonstrates that MALDI-TOF MS combined with tailored machine learning can deliver rapid, high-precision ribotype identification for C. difficile. The freely available AutoCdiff models ( https://bacteria.id ) offer an immediately deployable solution for clinical laboratories, with the potential to enhance outbreak surveillance and control.
No takes yet. Share an insight, caveat, or question.
Blázquez‐Sánchez et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: